Home Cart Sign in  
Chemical Structure| 25717-80-0 Chemical Structure| 25717-80-0

Structure of Molsidomine
CAS No.: 25717-80-0

Chemical Structure| 25717-80-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Molsidomine is a long-acting vasodilating drug used to treat angina pectoris.

Synonyms: SIN-10; Morsydomine; N-(Ethoxycarbonyl)-3-(4-morpholinyl)sydnone imine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Molsidomine

CAS No. :25717-80-0
Formula : C9H14N4O4
M.W : 242.23
SMILES Code : O=C([N-]C1=C[N+](N2CCOCC2)=NO1)OCC
Synonyms :
SIN-10; Morsydomine; N-(Ethoxycarbonyl)-3-(4-morpholinyl)sydnone imine
MDL No. :MFCD00869301
InChI Key :XLFWDASMENKTKL-UHFFFAOYSA-N
Pubchem ID :5353788

Safety of Molsidomine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P264-P270-P301+P312+P330-P501

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00382421 Myocardial Ischemia Not Applicable Completed - Switzerland ... More >> Department of Cardiology, Hospital Lucerne Lucerne, Switzerland, 6000 Less <<
NCT01363661 Stable Angina Pectoris ... More >> Atherosclerosis Less << Phase 4 Completed - Belgium ... More >> Onze Lieve Vrouw Ziekenhuis Aalst, Belgium, 9300 Less <<
NCT01363661 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.13mL

0.83mL

0.41mL

20.64mL

4.13mL

2.06mL

41.28mL

8.26mL

4.13mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories